Pharvaris (PHVS) Payables (2019 - 2026)

Pharvaris posted quarterly Payables of $3.2 million for Q1 2026, down 46.71% on a QoQ basis from $6.0 million in Q4 2025.

Pharvaris (PHVS) has 8 years of Payables data on file, last reported at $3.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Payables changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (changed N/A YoY), and the FY2025 full-year result was $5.8 million, up 17.0% from the prior year.
  • Payables for Q1 2026 stood at $3.2 million, down from $6.0 million in the prior quarter.
  • Across five years, Payables topped out at $6.1 million in Q4 2022 and bottomed at $3.1 million in Q4 2023.
  • The 5-year median for Payables is $4.9 million (2024), against an average of $4.6 million.
  • The widest annual swing landed in 2022, when Payables soared 114.11%; it then tumbled 48.68% in 2023.
  • A 5-year view of Payables shows it stood at $6.1 million in 2022, then sank by 48.68% to $3.1 million in 2023, then surged by 55.75% to $4.9 million in 2024, then climbed by 22.09% to $6.0 million in 2025, then sank by 46.71% to $3.2 million in 2026.
  • The last three Payables figures came in at $3.2 million (Q1 2026), $6.0 million (Q4 2025), and $4.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 300,549.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.05 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 83.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 10.62 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 8.69 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 489.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.03 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 126.63 Mn
10 Pharvaris 267.74 Mn -73.74 Mn - 3.17 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.17 Mn
Dec 31, 2025 5.95 Mn
Dec 31, 2024 4.88 Mn
Dec 31, 2023 3.13 Mn
Dec 31, 2022 6.10 Mn
Dec 31, 2021 2.85 Mn
Dec 31, 2020 782,676.29
Dec 31, 2019 573,114.34